M Madre1, E J Canales-Rodríguez1, J Ortiz-Gil1,2, A Murru3, C Torrent3, E Bramon4, V Perez5,6, M Orth7, P Brambilla8,9, E Vieta3, B L Amann1. 1. FIDMAG Research Foundation Germanes Hospitalàries, CIBERSAM, Barcelona, Spain. 2. Hospital General de Granollers, Granollers, Catalonia, Spain. 3. Bipolar Disorders Unit, Institute of Neuroscience, Hospital Clinic, IDIBAPS, CIBERSAM, University of Barcelona, Barcelona, Catalonia, Spain. 4. Division of Psychiatry, University College London, London, UK. 5. Institut de Neuropsiquiatria i Addiccions, Hospital del Mar, Barcelona, Spain. 6. CIBERSAM, IMIM (Institut Hospital del Mar d'Investigacions Mèdiques), Psiquiatria, Universitat Autònoma de Barcelona, Barcelona, Spain. 7. Department of Neurology, Ulm University, Ulm, Germany. 8. Department of Neurosciences and Mental Health, Psychiatric Clinic, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, University of Milan, Milan, Italy. 9. Department of Psychiatry and Behavioural Sciences, University of Texas Health Science Center at Houston, Houston, TX, USA.
Abstract
OBJECTIVES: The neurobiological basis and nosological status of schizoaffective disorder remains elusive and controversial. This study provides a systematic review of neurocognitive and neuroimaging findings in the disorder. METHODS: A comprehensive literature search was conducted via PubMed, ScienceDirect, Scopus and Web of Knowledge (from 1949 to 31st March 2015) using the keyword 'schizoaffective disorder' and any of the following terms: 'neuropsychology', 'cognition', 'structural neuroimaging', 'functional neuroimaging', 'multimodal', 'DTI' and 'VBM'. Only studies that explicitly examined a well defined sample, or subsample, of patients with schizoaffective disorder were included. RESULTS: Twenty-two of 43 neuropsychological and 19 of 51 neuroimaging articles fulfilled inclusion criteria. We found a general trend towards schizophrenia and schizoaffective disorder being related to worse cognitive performance than bipolar disorder. Grey matter volume loss in schizoaffective disorder is also more comparable to schizophrenia than to bipolar disorder which seems consistent across further neuroimaging techniques. CONCLUSIONS: Neurocognitive and neuroimaging abnormalities in schizoaffective disorder resemble more schizophrenia than bipolar disorder. This is suggestive for schizoaffective disorder being a subtype of schizophrenia or being part of the continuum spectrum model of psychosis, with schizoaffective disorder being more skewed towards schizophrenia than bipolar disorder.
OBJECTIVES: The neurobiological basis and nosological status of schizoaffective disorder remains elusive and controversial. This study provides a systematic review of neurocognitive and neuroimaging findings in the disorder. METHODS: A comprehensive literature search was conducted via PubMed, ScienceDirect, Scopus and Web of Knowledge (from 1949 to 31st March 2015) using the keyword 'schizoaffective disorder' and any of the following terms: 'neuropsychology', 'cognition', 'structural neuroimaging', 'functional neuroimaging', 'multimodal', 'DTI' and 'VBM'. Only studies that explicitly examined a well defined sample, or subsample, of patients with schizoaffective disorder were included. RESULTS: Twenty-two of 43 neuropsychological and 19 of 51 neuroimaging articles fulfilled inclusion criteria. We found a general trend towards schizophrenia and schizoaffective disorder being related to worse cognitive performance than bipolar disorder. Grey matter volume loss in schizoaffective disorder is also more comparable to schizophrenia than to bipolar disorder which seems consistent across further neuroimaging techniques. CONCLUSIONS: Neurocognitive and neuroimaging abnormalities in schizoaffective disorder resemble more schizophrenia than bipolar disorder. This is suggestive for schizoaffective disorder being a subtype of schizophrenia or being part of the continuum spectrum model of psychosis, with schizoaffective disorder being more skewed towards schizophrenia than bipolar disorder.
Authors: Faith M Hanlon; Ronald A Yeo; Nicholas A Shaff; Christopher J Wertz; Andrew B Dodd; Juan R Bustillo; Shannon F Stromberg; Denise S Lin; Swala Abrams; Jingyu Liu; Andrew R Mayer Journal: Schizophr Res Date: 2019-01-31 Impact factor: 4.939
Authors: Amanda L Rodrigue; Jennifer E McDowell; Neeraj Tandon; Matcheri S Keshavan; Carol A Tamminga; Godfrey D Pearlson; John A Sweeney; Robert D Gibbons; Brett A Clementz Journal: Biol Psychiatry Cogn Neurosci Neuroimaging Date: 2018-03-31
Authors: Amanda L Rodrigue; Dana Mastrovito; Oscar Esteban; Joke Durnez; Marinka M G Koenis; Ronald Janssen; Aaron Alexander-Bloch; Emma M Knowles; Samuel R Mathias; Josephine Mollon; Godfrey D Pearlson; Sophia Frangou; John Blangero; Russell A Poldrack; David C Glahn Journal: Biol Psychiatry Cogn Neurosci Neuroimaging Date: 2020-12-16
Authors: Faith M Hanlon; Andrew B Dodd; Josef M Ling; Nicholas A Shaff; David D Stephenson; Juan R Bustillo; Shannon F Stromberg; Denise S Lin; Sephira G Ryman; Andrew R Mayer Journal: Schizophr Res Date: 2021-02-17 Impact factor: 4.939
Authors: Marco Solmi; Andrea Murru; Isabella Pacchiarotti; Juan Undurraga; Nicola Veronese; Michele Fornaro; Brendon Stubbs; Francesco Monaco; Eduard Vieta; Mary V Seeman; Christoph U Correll; André F Carvalho Journal: Ther Clin Risk Manag Date: 2017-06-29 Impact factor: 2.423
Authors: Mohanbabu Rathnaiah; Elizabeth B Liddle; Lauren Gascoyne; Jyothika Kumar; Mohammad Zia Ul Haq Katshu; Catherine Faruqi; Christina Kelly; Malkeet Gill; Sian Robson; Matt Brookes; Lena Palaniyappan; Peter Morris; Peter F Liddle Journal: Schizophr Bull Open Date: 2020-06-25